Meridian Bioscience Inc. (VIVO) -0.15

Trade VIVO
NOW!
Last Trade:20.43Short Ratio:17.90
Last Trade Time:4:00pmDay Range:20.35 - 20.71
Ask:Year Range:14.79 - 26.20
Bid:20.26One Year Target:23.20
Open:20.49Exchange:NasdaqNM
Volume:770100EBITDA:54.8M
Prev. Close:20.58Market Cap:829.5M
50 Day Moving:21.5267Div Yield:3.40
200 day moving:22.442PE:25.19

William Blair & Company Maintains Meridian Bioscience (VIVO) Market Perform Rating

Posted on 03/18/10 at 11:43am
William Blair & Company analyst Brian Weinstein maintained his Market Perform rating for shares of Meridian Bioscience Inc. (Nasdaq: VIVO). Although Meridian Bioscience Inc. lowered its sales and earnings guidance significantly, the main reason behind the move was an industry wide issue.
Click here to read the rest of the article
Posted in

US Market Stocks Movers on News (ACTL, VIVO, LSI)

Posted on 03/18/10 at 3:00am
(EMAILWIRE.COM, March 18, 2010 ) Dallas, Tx - Actel Corporation (NASDAQ:ACTL) lost 1.72% to $13.69 after the company today announced that first quarter 2010 revenues are expected to be up sequentially four percent to eight percent. The previous guidance was up two percent to six percent.
Click here to read the rest of the article

US Stock Market Notable Downgrades are PLCM, IPXL, WNI, FEN, VIVO, ARIA

Posted on 03/18/10 at 3:00am
(EMAILWIRE.COM, March 18, 2010 ) Dallas, Tx - Polycom, Inc. (NASDAQ:PLCM) fell 2.29% to $32.38 after BofA/Merrill Lynch downgraded their rating on the company's share from Buy to Neutral and raised the price target by $3 to $35.
Click here to read the rest of the article

Meridian Bioscience Revises Guidance for Fiscal 2010 and Comments on Preliminary Second Quarter Operating Results and Business Outlook Including illumigene™ Update

Posted on 03/17/10 at 7:12am
CINCINNATI--(BUSINESS WIRE)-- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010.
Click here to read the rest of the article

Notable First Hour Stock Movers after Guidance (VIVO, LSI, ACTL, WLP)

Posted on 03/17/10 at 3:00am
(EMAILWIRE.COM, March 17, 2010 ) Dallas, Tx - Meridian Bioscience, Inc. (NASDAQ:VIVO) lost 15.43% to $20.08 after it announced today announced that it is revising downward its previous sales and earnings guidance for the fiscal year ending September 30, 2010.
Click here to read the rest of the article

Investors Bid Up Shares of Meridian Bioscience, Up 0.7% (VIVO)

Posted on 03/15/10 at 12:36pm
Meridian Bioscience (NASDAQ: VIVO) is one of today's best performing stocks, up 0.7% to $23.66. The S&P is currently trading 0.6% lower to 1,142 and the Dow Jones Industrial Average is trading 0.4% lower to 10,580.
Click here to read the rest of the article

Meridian Bioscience: The Trend Continues Up (VIVO)

Posted on 03/12/10 at 6:30am
SmarTrend identified an Uptrend for Meridian Bioscience (NASDAQ: VIVO) on February 24, 2010 at $21.82. In approximately 2 weeks, Meridian Bioscience has returned 6.8% as of today's recent price of $23.31.
Click here to read the rest of the article

SmarTrend's Candlestick Scanner Detects Bullish Engulfing Pattern for Meridian Bioscience (VIVO)

Posted on 03/08/10 at 8:51am
SmarTrend's candlestick pattern scanner has detected a bullish engulfing pattern for shares of Meridian Bioscience (NASDAQ: VIVO) since the stock closed above $23.01.
Click here to read the rest of the article

4Q09 Results: VIVO Participacoes S.A.

Posted on 02/10/10 at 6:03am
SAO PAOLO, Feb. 10 /PRNewswire-FirstCall/ -- VIVO Participacoes S.A. (VIVO) (NYSE: VIV; Bovespa: VIVO3 [ON = Common Shares] / VIVO4 [PN = Preferred Shares]), announced its consolidated results for the fourth quarter 2009 (4Q09) and for full-year 2009.
Click here to read the rest of the article